Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: Promising, safe and cheap

Journal of the Neurological Sciences

Volumn 264, Issue 1-2, 2008, Pages 129-132

  Sinha, S ^a   Taly, A B ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Penicillamine withdrawal; Treatment; Wilson disease; Zinc sulphate; Zinc therapy treatment of choice

Indexed keywords

PENICILLAMINE; ZINC SULFATE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG WITHDRAWAL; DYSARTHRIA; FEMALE; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MALE; MEDICAL ASSESSMENT; PATIENT ASSESSMENT; PHYSICAL DISABILITY; PRIORITY JOURNAL; SAMPLE SIZE; SCORING SYSTEM; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; WILSON DISEASE;

ADOLESCENT; ADULT; ASTRINGENTS; CHELATING AGENTS; CHELATION THERAPY; CHILD; CHILD, PRESCHOOL; COPPER; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; PENICILLAMINE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; ZINC SULFATE;

EID: 36549056479     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.08.006     Document Type: Article

References (27)

1. Walshe J.M. Wilson's disease. In: Vinken P.J., Bruyn G.W., and Klawans H.L. (Eds). Handbook of clinical neurology vol. 49 (1986), Elsevier, Amsterdam 223-238
2. Brewer G.J., and Yuzbasiyan-Gurkan V. Wilson disease. Medicine 71 (1992) 139-164
3. Brewer G.J. Wilson's disease. a clinician's guide to recognition, diagnosis and management (2001), Kluwer Academic Publishers, Boston
4. Taly A.B., Meenakshi-Sundaram S., Sinha S., Swamy H.S., and Arunodaya G.R. Wilson disease: description of 282 patients evaluated over three decades. Medicine 86 2 (2007) 112-121
5. Schouwink G. De hepatocerebrale degeneratie, met een onderzoek naar de koperstofwisseling. University of Amsterdam MD thesis; 1961
6. Hoogenraad T.U., Van den Hamer C.J., Koevoet R., and Korver E.G. Oral zinc in Wilson's disease. Lancet 2 8102 (1978) 1262
7. Hoogenraad T.U., Koevoet R., and de Ruyter Korver E.G. Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 18 3 (1979) 205-211
8. Hoogenraad T.U., Van Hattum J., and Van den Hamer C.J. Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients. J Neurol Sci 77 2-3 (1987) 137-146
9. Scheinberg I.H., and Sternlieb I. Wilson's Disease. Wilson's disease (1984), WB Saunders, Philadelphia
10. Brewer G.J., Terry C.A., Aisen A.M., and Hill G.M. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 44 (1987) 490-493
11. Hoogenraad T.U. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev 28 3 (2006) 141-146
12. Brewer G.J., Dick R.D., Johnson V.D., Brunberg J.A., Kluin K.J., and Fink J.K. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med 132 4 (1998) 264-278
13. Brewer G.J. Treatment of Wilson's disease with zinc. J Lab Clin Med 134 3 (1999) 322-324
14. Brewer G.J., Dick R.D., Yuzbasiyan-Gurkan V., Johnson V., and Wang Y. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis. J Lab Clin Med 123 6 (Jun 1994) 849-858
15. Walshe J.M., and Yealland M. Chelation treatment of neurological Wilson's disease. Q J Med 86 (1993) 197-204
16. Walshe J.M. Penicillamine: the treatment of first choice for patients with Wilson's disease. Mov Disord 14 4 (1999) 545-550
17. Brewer G.J. Penicillamine should not be used as initial therapy in Wilson's disease. Mov Disord 14 4 (1999) 551-554
18. Prashanth L.K., Taly A.B., Sinha S., Ravishankar S., Arunodaya G.R., Vasudev M.K., et al. Factors that influence prognosis in severe forms of Wilson Disease. Q J Med 98 8 (2005) 557-563
19. Veen C., van den Hamer C.J., and de Leeuw P.W. Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose d-penicillamine. J Intern Med 229 6 (1991) 549-552
20. Hoogenraad T.U. Dangers of interrupting de-coppering treatment in Wilson's disease. Arch Neurol 51 (1994) 972-973
21. Yuzbasiyan-Gurkan V., Grider A., Nostrant T., Cousins R.J., and Brewer G.J. Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction. J Lab Clin Med 120 3 (1992) 380-386
22. Brewer G.J., Hill G.M., Dick R.D., Nostrant T.T., Sams J.S., Wells J.J., et al. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper. J Lab Clin Med 109 5 (1987) 526-531
23. Brewer G.J., Johnson V., and Kaplan J. Treatment of Wilson's disease with zinc: XIV. Studies of the effect of zinc on lymphocyte function. J Lab Clin Med 129 6 (1997) 649-652
24. Brewer G.J., Yuzbasiyan-Gurkan V., and Johnson V. Treatment of Wilson's disease with zinc. IX: Response of serum lipids. J Lab Clin Med 118 5 (1991) 466-470
25. Yuzbasiyan-Gurkan V., Brewer G.J., Abrams G.D., Main B., and Giacherio D. Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease. J Lab Clin Med 114 5 (1989) 520-526
26. Sinha S., Taly A.B., Prashanth L.K., Arunodaya G.R., and Swamy H.S. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson's disease. J Neurol Sci 217 (2004) 37-40
27. Brewer G.J., Johnson V.D., Dick R.D., Hedera P., Fink J.K., and Kluin K.J. Treatment of Wilson's disease with zinc xvii: treatment during pregnancy. Hepatology 31 2 (2000) 364-370